Bladder transitional cell carcinoma and BK virus in a young kidney transplant recipient

Transplant Infectious Disease

Volumn 15, Issue 1, 2013, Pages

  Pino, L ^a   Rijo, E ^a   Nohales, G ^a   Frances, A ^a   Ubre, A ^a   Arango, O ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

BK virus; Bladder cancer; Kidney transplant; Transitional cell carcinoma

Indexed keywords

CIDOFOVIR; MYCOPHENOLIC ACID; TACROLIMUS;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BK VIRUS INFECTION; BLADDER CARCINOMA; BLADDER TRANSITIONAL CELL CARCINOMA; CANCER CYTODIAGNOSIS; CASE REPORT; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; CYSTECTOMY; GRAFT RECIPIENT; HEMATURIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; URINALYSIS;

ADULT; BK VIRUS; CARCINOMA, RENAL CELL; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; MALE; NEOPLASMS, MULTIPLE PRIMARY; OPPORTUNISTIC INFECTIONS; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; URINARY BLADDER NEOPLASMS;

EID: 84873425662     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12042     Document Type: Article

References (18)

1. Abend JR, Jiang M, Imperiale MJ. BK virus and human cancer: innocent until proven guilty. Semin Cancer Biol 2009; 19: 252-260.
2. Doerries K. Human polyomavirus JC and BK persistent infection. Adv Exp Med Biol 2006; 577: 102-116.
3. Hirsch HH. BK virus: opportunity makes a pathogen. Clin Infect Dis 2005; 41: 354-360.
4. Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971; 1 (7712): 1253-1257.
5. Knowles WA. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). Adv Exp Med Biol 2006; 577: 19-45.
6. Roberts IS, Besarani D, Mason P, Turner G, Friend PJ, Newton R. Polyoma virus infection and urothelial carcinoma of the bladder following renal transplantation. Br J Cancer 2008; 99: 1383-1386.
7. Monini P, Rotola A, Di Luca D, et al. DNA rearrangements impairing BK virus productive infection in urinary tract tumours. Virology 1995; 214: 273-279.
8. Weinreb DB, Desman GT, Amolat-Apiado MJ, Burstein DE, Godbold JH Jr, Johnson EM. Polyoma virus infection is a prominent risk factor for bladder carcinoma in immunocompetent individuals. Diagn Cytopathol 2006; 34: 201-203.
9. Imperiale MJ. Oncogenic transformation by the human polyomaviruses. Oncogene 2001; 20: 7917-7923.
10. Moriyama T, Marquez JP, Wakatsuki T, Sorokin A. Caveolar endocytosis is critical for BK virus infection of human renal proximal tubular epithelial cells. J Virol 2007; 81: 8552-8562.
11. Moriyama T, Sorokin A. Intracellular trafficking pathway of BK virus in human renal proximal tubular epithelial cells. Virology 2008; 20: 336-349.
12. Kahan AV, Coleman DV, Koss LG. Activation of human polyomavirus infection-detection by cytologic technics. Am J Clin Pathol 1980; 74: 326-332.
13. Newton R, Ribeiro T, Casabonne D, et al. Antibody levels against BK virus and prostate, kidney and bladder cancers in the EPIC-Oxford cohort. Br J Cancer 2005; 11: 1305-1306.
14. Russo G, Anzivino E, Fioriti D, et al. p53 gene mutational rate, Gleason score, and BK virus infection in prostate adenocarcinoma: is there a correlation? J Med Virol 2008; 80: 2100-2107.
15. Balis V, Sourvinos G, Soulitzis N, Giannikaki E, Sofras F, Spandidos DA. Prevalence of BK virus and human papillomavirus in human prostate cancer. Int J Biol Markers 2007; 22: 245-251.
16. Pipas JM, Levine AJ. Role of T antigen interactions with p53 in tumorigenesis. Semin Cancer Biol 2001; 11: 23-30.
17. Wang HH, Liu KL, Chu SH, Tian YC, Lai PC, Chiang YJ. BK virus infection in association with posttransplant urothelial carcinoma. Transplant Proc 2009; 41: 165-166.
18. Knepper JE, diMayorca G. Cloning and characterization of BK virus-related DNA sequences from normal and neoplastic human tissues. J Med Virol 1987; 21: 289-299.